ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 66 filers reported holding ACUMEN PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JPMORGAN CHASE & CO | 11,025 | $45,974 | 0.00% |
| BARCLAYS PLC | 22,425 | $93 | 0.00% |
| ROYAL BANK OF CANADA | 102 | $0 | 0.00% |
| VANGUARD GROUP INC | 1,856,552 | $7,704,691 | 0.00% |
| JANE STREET GROUP, LLC | 16,788 | $69,670 | 0.00% |
| UBS Group AG | 100 | $415 | 0.00% |
| OSAIC HOLDINGS, INC. | 200 | $830 | 0.00% |
| FMR LLC | 657 | $2,727 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 75,602 | $313,749 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 16,475 | $68,372 | 0.00% |
| WELLS FARGO & COMPANY/MN | 194 | $805 | 0.00% |
| NORTHERN TRUST CORP | 56,190 | $233,189 | 0.00% |
| AMERICAN CENTURY COMPANIES INC | 13,816 | $57,336 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 264,603 | $1,098,390 | 0.00% |
| STATE STREET CORP | 59,778 | $248,079 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 53,800 | $223,270 | 0.00% |
| MARSHALL WACE, LLP | 25,492 | $105,792 | 0.00% |
| CITIGROUP INC | 38,498 | $159,767 | 0.00% |
| GOLDMAN SACHS GROUP INC | 57,299 | $237,791 | 0.00% |
External links
This page lists ACUMEN PHARMACEUTICALS INC's shareholders in Q3 2023. To view ACUMEN PHARMACEUTICALS INC's shareholder history, click here.